IM Cannabis (IMCC) Shares Outstanding (2019 - 2026)
IM Cannabis (IMCC) posted quarterly Shares Outstanding (Entity) of $328511.0 for Q1 2026, down 94.43% quarter-over-quarter from $5.9 million in Q4 2025.
IM Cannabis (IMCC) Shares Outstanding (2019 - 2026) Analysis & Trends
IM Cannabis' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $328511.0 for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) changed N/A year-over-year to $328511.0; the TTM figure through Mar 2026 stood at $328511.0 (changed N/A YoY), while the FY2025 annual figure was $5.9 million, up 91.05% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $328511.0, down from $5.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $5.9 million in Q4 2025, with the low at $6268.0 in Q2 2023.
- The 5-year median for Shares Outstanding (Entity) is $2.2 million (2024), against an average of $2.4 million.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) plunged 99.46% in 2023, then jumped 35509.44% in 2024.
- IM Cannabis' Shares Outstanding (Entity) stood at $1.3 million in 2022, then surged by 76.95% to $2.2 million in 2023, then jumped by 38.21% to $3.1 million in 2024, then jumped by 91.05% to $5.9 million in 2025, then slumped by 94.43% to $328511.0 in 2026.
- Business Quant data shows IMCC's Shares Outstanding (Entity) at $328511.0 in Q1 2026, $5.9 million in Q4 2025, and $4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 832.44 Mn |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn | 4.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.86 Mn |
| Mar 31, 2026 | 4.86 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Sep 30, 2025 | 4.86 Mn |
| Jun 30, 2025 | 3.26 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Mar 31, 2024 | 2.14 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 6,268.00 |
| Jun 30, 2023 | 6,268.00 |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 966,069.00 |
| Dec 31, 2021 | 966,069.00 |
| Sep 30, 2021 | 81,685.00 |